{"id":632635,"date":"2025-06-24T16:10:12","date_gmt":"2025-06-24T20:10:12","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=632635"},"modified":"2025-06-24T16:11:47","modified_gmt":"2025-06-24T20:11:47","slug":"tirzepatide-vs-semaglutide-cost","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/tirzepatide-vs-semaglutide-cost\/","title":{"rendered":"Tirzepatide vs. semaglutide cost"},"content":{"rendered":"

Tirzepatide and semaglutide<\/span><\/a> have become household names, mostly thanks to their effectiveness in body weight reduction. Tirzepatide is the active ingredient in the brand-name drugs <\/span>Mounjaro<\/span><\/a> and <\/span>Zepbound<\/span><\/a>, while semaglutide is the active ingredient in brand-name drugs <\/span>Ozempic<\/span><\/a>, <\/span>Wegovy<\/span><\/a>, and <\/span>Rybelsus<\/span><\/a>. There are also compounded versions of tirzepatide and semaglutide, but they are not approved by the Food and Drug Administration (FDA). In fact, the FDA has directed American compounding pharmacies to stop producing these products.\u00a0<\/span><\/p>\n

These drugs have similar side effects, risk factors, and mechanisms of action, so people may wonder which is cheaper. Below, find out more about how much they cost, whether they tend to be covered by insurance, and more.<\/span><\/p>\n

What\u2019s the difference between tirzepatide and semaglutide?<\/span><\/h2>\n

The main difference between tirzepatide and semaglutide is that they are the key ingredients in different weight-loss medications. Tirzepatide is available under the brand names Mounjaro and Zepbound, whereas semaglutide is available under the brand names Ozempic, Wegovy, and Rybelsus. But they have different drug classifications, indications, and dosages.<\/span><\/p>\n

Drug classification<\/span><\/h3>\n

Tirzepatide and semaglutide also belong to slightly different drug classes. Semaglutide is a <\/span>glucagon-like peptide-1 (GLP-1) receptor agonist<\/span><\/a>. Tirzepatide, on the other hand, is a glucose-dependent insulinotropic polypeptide (GIP) receptor <\/span>and<\/span><\/i> GLP-1 receptor agonist\u2014sometimes called a dual GIP\/GLP-1 receptor agonist.<\/span><\/p>\n

FDA-approved indications<\/span><\/h3>\n

In a head-to-head comparison, tirzepatide and semaglutide work the same way: They mimic naturally occurring hormones to stimulate insulin production, thus regulating blood sugar and suppressing appetite. However, each brand-name drug has a slightly different FDA-approved purpose:<\/span><\/p>\n

Tirzepatide indications:<\/strong><\/h4>\n